Carbidopa + Levodopa price in the Philippines
Quick answer
The DOH reference price for carbidopa + levodopa 100 mg + 25 mg tablet is ₱13.80 per tablet (median, June 2024 index); drugstore prices are usually higher. FDA Philippines lists 25 registered carbidopa + levodopa products (checked 2026-11-05): 3 as unbranded generics and 22 under 15 brand names. It is a prescription (Rx) medicine. Ask the pharmacist for the unbranded generic of the same strength.
Government reference price
At the DOH median, 30 tablets cost about ₱414.00, a month at one a day.
DPRI range, DOH DPRI June 2024. What public hospitals pay; drugstore prices are usually higher.
DOH reference prices
Carbidopa + Levodopa: DOH reference prices
2 items in the DOH index; the lowest median is ₱13.80 for carbidopa + levodopa 100 mg + 25 mg tablet.
| Item | Lowest (₱) | Median (₱) | Highest (₱) | Type |
|---|---|---|---|---|
| Carbidopa + Levodopa 100 mg + 25 mg Tablet | ₱11.00 | ₱13.80 | ₱14.00 | DPRI range |
| Carbidopa + Levodopa 250 mg + 25 mg Tablet | ₱17.80 | ₱20.00 | ₱22.97 | DPRI range |
Source: DOH Drug Price Reference Index, June 2024. Prices per unit (tablet, vial, bottle) in pesos, VAT included unless the medicine is VAT-exempt. Hospitals and other facilities may price up to 6.8% above the index, except MWP items.
Strengths
Carbidopa + Levodopa by strength
Carbidopa + Levodopa is listed here in 4 strengths; 3 of them (25 mg + 100 mg, 25 mg + 250 mg, 50 mg + 200 mg) have FDA-registered products in the Philippines.
| Strength | FDA products |
|---|---|
| Carbidopa + Levodopa 10 mg + 100 mg | not registered |
| Carbidopa + Levodopa 25 mg + 100 mg | 8 |
| Carbidopa + Levodopa 25 mg + 250 mg | 14 |
| Carbidopa + Levodopa 50 mg + 200 mg | 3 |
Sources: FDA Philippines registry (2026-11-05), DOH DPRI June 2024.
About carbidopa + levodopa
Used for
This medicine combines carbidopa and levodopa in one tablet. The US FDA label for carbidopa and levodopa extended-release tablets lists:
- Parkinson's disease
- parkinsonism after brain inflammation (encephalitis)
- parkinsonism that can follow carbon monoxide or manganese poisoning
This page follows the US label for the extended-release tablets (25 mg/100 mg and 50 mg/200 mg). The regular tablets sold here, such as 25 mg/100 mg and 25 mg/250 mg, have their own leaflet with their own doses.
How it works
Parkinson's symptoms are linked to a lack of dopamine in part of the brain. Dopamine itself cannot reach the brain, but levodopa can, and it is turned into dopamine there. Carbidopa stops levodopa from being broken down in the rest of the body, so more of it reaches the brain. The extended-release tablet gives steadier levodopa levels.
How to take it and usual dose
The daily dose is found step by step, with close watch for nausea and new or worse involuntary movements. Swallow the tablets without chewing or crushing them. People switching from plain levodopa must stop it at least 12 hours before starting. Those moving from regular carbidopa-levodopa tablets usually need about 10% more levodopa per day, as the extended-release tablet releases less. Your doctor decides the dose.
Do not use if
- you take a nonselective MAO inhibitor, or stopped one less than 2 weeks ago
- you have narrow-angle glaucoma
- you are allergic to any ingredient
Common side effects
The most frequent are:
- uncontrolled, jerky movements (dyskinesia)
- nausea
- seeing things that are not there
- confusion
- dizziness
- low mood
Headache, vivid dreams, muscle stiffness or cramps, vomiting and urinary infections were also reported. The label asks for close watch for depression with suicidal thoughts. Hallucinations often appear early and may ease with a lower dose.
Source: US FDA label (DailyMed), 2026-03-19. A summary of the official label, not medical advice: your doctor or pharmacist knows your case.
Registered products
Registered carbidopa + levodopa products
FDA Philippines lists 25 registrations under 16 brand names (one row is unbranded generics).
| Brand | Strength and form | Class | Manufacturer | Reg. |
|---|---|---|---|---|
| Lavida | 100 mg / 25 mg Tablet; 250 mg / 25 mg Tablet | Rx | UNILAB, INC. (Philippines) | 2 |
| LC-Dopa | 100 mg/25 mg Tablet; 250 mg/25 mg Tablet | Rx | Baroque Pharmaceuticals Pvt. Ltd. (India) +1 more | 4 |
| Levocarbdin | 100 mg/25 mg Tablet; 250 mg/25 mg Tablet | Rx | Medochemie Ltd. (Central Factory) (Cyprus) | 2 |
| Medolev 125 | 100 mg/25 mg Tablet | Rx | Medochemie Ltd. (Central Factory) (Cyprus) | 1 |
| Medolev 275 | 250 mg/25 mg Tablet | Rx | Medochemie Ltd. (Central Factory) (Cyprus) | 1 |
| Pardopa | 250 mg/25 mg Tablet | Rx | Micro Labs Limited (India) | 1 |
| Parkimet 125 | 100 mg/ 25 mg Tablet | Rx | Sun Pharma Philippines, Inc. (India) | 1 |
| Roligvo 250 | 250 mg / 25 mg Tablet | Rx | Exemed Pharmaceuticals (India) | 1 |
Show 8 more brands
Registered carbidopa + levodopa products, continued
| Brand | Strength and form | Class | Manufacturer | Reg. |
|---|---|---|---|---|
| Sinedin | 100 mg/25 mg Tablet; 250 mg / 25 mg Tablet | Rx | Sydenham Laboratories, Inc. (Philippines) | 2 |
| Tidomet | 250 mg/25 mg Tablet | Rx | TORRENT PHARMACEUTICALS LTD. (India) | 1 |
| Tidomet CR | 200 mg/50 mg Controlled Release Tablet | Rx | Torrent Pharmaceuticals Ltd. (India) | 1 |
| Twindopa | 250mg / 25mg Tablet | Rx | Kusum Healthcare Pvt. Ltd. (India) | 1 |
| Vexdopa | 250 mg/25 mg Tablet | Rx | Medochemie Ltd. (Central Factory) (Cyprus) +1 more | 2 |
| Vexdopa 125 | 100 mg/25 mg Tablet | Rx | West Coast Pharmaceutical Works Ltd. (India) | 1 |
| Vexdopa 250 CR | 200 mg/50 mg Controlled-Release Tablet | Rx | West Coast Pharmaceutical Works Ltd. (India) | 1 |
| No brand (generic) | 200 mg/50 mg Controlled Release Tablet; 250 mg / 25 mg Tablet; 250 mg/25 mg Tablet | Rx | Micro Labs Limited (India) +2 more | 3 |
Source: FDA Philippines product registry, checked 2026-11-05. Look up any registration number at verification.fda.gov.ph.
Official leaflets
The package insert (PI) and patient leaflet (PIL) filed with FDA Philippines. Doses, side effects and warnings are there, written by the maker and approved by FDA.
- Pardopa: package insert (PI) (DR-XY40429)
- Sinedin: package insert (PI) (DR-XY41871)
- Sinedin: package insert (PI) (DR-XY41327)
- TIDOMET: package insert (PI) (DRP-2770)
Paying less for carbidopa + levodopa
- Ask for the generic
Prescriptions are written in generic names, and the pharmacist must tell you every brand of that generic and its price. How it works
- Senior or PWD card
20% off plus no VAT on your own medicines, with ID and prescription. What to bring
Questions people ask
Do I need a prescription for carbidopa + levodopa in the Philippines?
FDA Philippines classifies carbidopa + levodopa as a prescription (Rx) medicine. A pharmacist may dispense it only against a valid prescription (Pharmacy Act, RA 10918).
Is there a generic carbidopa + levodopa registered in the Philippines?
FDA Philippines lists 25 registered carbidopa + levodopa products (checked 2026-11-05): 3 sold under the generic name only and 22 under 15 brand names. Ask the pharmacist for the unbranded generic: same ingredient and strength.
How much does carbidopa + levodopa cost in the Philippines?
The DOH Drug Price Reference Index, June 2024 edition, lists carbidopa + levodopa 100 mg + 25 mg tablet at a median of ₱13.80 (range ₱11.00 to ₱14.00). That is what public hospitals pay; drugstore prices are usually higher.
Where can I buy carbidopa + levodopa legally?
From an FDA-licensed drugstore or botika; the licence to operate (LTO) should be displayed in the store. Bring your prescription. Check that the box carries a DR- registration number, and be careful with online sellers that are not licensed pharmacies.
Is carbidopa-levodopa over the counter in the Philippines?
No. FDA Philippines lists all registered products, such as 100 mg/25 mg and 250 mg/25 mg tablets, as prescription (Rx) drugs.
Can I crush carbidopa-levodopa extended-release tablets?
No. The label says the extended-release tablets should not be chewed or crushed.
Data: FDA Philippines registry (checked 2026-11-05), DOH Drug Price Reference Index (June 2024). Sources and method.